Bristol Myers Squibb 2022 Golden Ticket Contest at MBC BioLabs

The Bristol Myers Squibb Golden Ticket Contest at MBC BioLabs is a contest that awards two laboratory bench spots (comprised of one year of laboratory space for biomedical research at MBC BioLabs) to two innovative biotech start-ups pursuing research in the fields of oncology, hematology, immunoscience, cardiovascular disease, neuroscience or fibrotic diseases that best meet the judging criteria of the Contest, or, in the sole discretion of the Judges, the one innovative biotech start-up that best meets the judging criteria will be awarded two laboratory bench spots at MBC BioLabs.

Eligibility

To be eligible to participate to have the opportunity to receive the Award, the Applicant must:

  • (1) be an entity formed under the laws of the United States;
  • (2) not have raised more than $7.5 million United States dollars in capital or have trailing twelve month revenue of more than $3 million United States dollars as of the time of Application and the closing date for the Contest;
  • (3) submit a complete Application;
  • (4) represent and warrant that the Applicant has read and agrees to abide by all requirements of these Rules;
  • (5) not be affiliated with or employed by Bristol Myers Squibb or MBC BioLabs including as an employee, contractor, officer or director of Bristol Myers Squibb or MBC BioLabs and including as an immediate family member of Bristol Myers Squibb or MBC BioLabs (including parents, spouses, children, siblings or any individual residing in the household of a Bristol Myers Squibb or a MBC BioLabs employee, officer or director (whether or not related)); and
  • (6) not be an academic institution such as a college, university or school.

By submitting an Application, each Applicant, all of Applicant’s team members, employees, contractors, owners, investors, agents, directors, officers and any other affiliated individual or company with Applicant, agrees to the terms and conditions of these Official Rules.

How to Apply

Applicant may submit only one entry to the Contest during the Application Period.

The Application for the Contest can be found below and must be completed in full and include an accurate description of the Applicant’s non-confidential research in the fields of oncology, hematology, immunoscience, cardiovascular, neuroscience or fibrosis, including for novel target identification, drug delivery, discovery technology platforms, or translational research and development. Applicant must legibly complete each section of the Application in English and may not exceed the space provided for in the Application. Applicants must also provide a non-confidential deck of no more than ten slides. Slides must address unmet medical need, solution, scientific principle, key data supporting the scientific principle, overview of business case, intellectual property, and highlight the team. All Applications become the property of Sponsor and cannot be acknowledged or returned.

The Application must also provide the name of the entity submitting the Application, the state of formation, a description of how it is eligible, contact information including a point-person to communicate with BMS about the Contest.

All costs incurred by Applicants in submitting an Application and/or presenting at the Pitch Event, if selected, are the sole responsibility of Applicants.

Deadline of Application

Applications can be submitted through August 22, 2022 at 11:59 PM PST.

Judging Criteria and Judges

The Judges for the Contest are the Bristol Myers Squibb Golden Ticket Committee, which consists of Bristol Myers Squibb employees who are qualified experts in their fields, including in the fields of scientific and/or medical research and business. Judges shall have authority to make decisions as to the Award Recipients.

Applications will be judged using the following criteria:

  • Fit of the research in the fields of oncology, hematology, immunoscience, cardiovascular, neuroscience or fibrosis; including for novel target identification, drug delivery, discovery technology platforms, or translational research and development.
  • Quality of the work;
  • Potential for successful development of the research; and
  • Need for the research in the applicable field

Judges will select a sub-set of the Applicants as Finalists. Finalists will be requested to present their concept as part of a Bristol Myers Squibb virtual innovation event to be held on or about October 12, 2022. All innovation event presentations will be non-confidential.

Between August 22, 2022 and September 01, 2022, the Judges may contact Applicants for additional information. If so contacted, Applicant must respond to such request in order to remain eligible to have the opportunity to win the Award. The Decisions of the Judges shall be final and binding on all Applicants and cannot be challenged in any manner.

Restrictions on Content of Application

Applications and pitch decks and innovation event presentations may only contain non-confidential information about Applicant’s research.

Applications may not contain: material or information that violates or infringes a third party’s rights including but not limited to any privacy, publicity, trade secret, confidential or intellectual property rights including but not limited to patent, copyright or trademark.

Limitation of Liability, Waivers and Releases

BRISTOL MYERS SQUIBB SHALL HAVE NO LIABILITY FOR ANY PERSONAL INJURIES, DEATH, PROPERTY DAMAGE OR OTHER DAMAGES OR EXPENSES RESULTING FROM OR ARISING OUT OF USE OF THE AWARD OR ANY OTHER ASPECT OF AN AWARD RECIPIENT’S ACCEPTANCE OR USE OF THE AWARD.

By submitting an Application, Applicant also agrees and acknowledges that any and all research disclosed in the Application and in connection with the Judging of the Application, not otherwise covered by a confidentiality agreement, including any ideas, inventions, patents, suggestions, concepts, copyrights and any other information will be publicly disclosed, will be reviewed and available to Bristol Myers Squibb and MBC BioLabs, and may be available to a third party. As a result, Applicant agrees to waive all rights, claims and any cause of action Applicant may have against Bristol Myers Squibb and/or MBC BioLabs, including its patents, affiliated entities, advisors, agents, licensees, employees, contractors, directors and officers, arising out of or related to any ideas, suggestions and/or concepts that may be disclosed in the Application and/or the Judging process in any form fashion or respect.

By submitting an Application, Applicant agrees to these Official Rules and the decisions of Bristol Myers Squibb and MBC BioLabs, on behalf of the Applicant each of its affiliated entities or persons, including but not limited to Applicant’s employees, contractors, team members, owners, directors, officers, managers, owners, investors, respective heirs, executors, administrators, legal representatives, successors and assigns (“Releasing Party”), and by submitting an Application, an Applicant hereby does release, defend and hold harmless Bristol Myers Squibb and MBC BioLabs and any of their affiliates, subsidiaries, advisors and individuals acting as judges, and their respective officers, directors and employees as applicable (“Released Parties”) from any and all causes of action, suits, debts, dues, sums of money, accounts, reckonings, bonds, bills, covenants, contracts, controversies, promises, lost profits, indirect or direct damages, consequential damages, incidental damages, punitive or exemplary damages, judgments, claims and demands whosoever, in law, or equity, whether known or unknown, foreseen or unforeseen, which any Releasing Party has or may ever had, now or hereafter, arising out of or related to Contest, any Application including any research identified in the Application or in the Judging process, the Award, use or inability to use or be awarded the Award, these Rules, the preparation of any Application, delivery, misdelivery, acceptance, possession, attendance at, travel related to, misuse, and/or use of or inability to use the Award including but not limited to any claims related to any of Applicant’s intellectual property, trade secrets, confidential information, corporate opportunities, prospective business or contracts, contractual agreements, any oral or written statements made to Bristol Myers Squibb or any statements made by Bristol Myers Squibb in any way related to the Contest, during the Contest or related to Judges or the judging process for the Contest

Bristol Myers Squibb Golden Ticket Application

Please submit required information until August 22nd to be considered!

Choose File
Choose File